Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1982-10-19
1984-10-16
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
A61K 31425
Patent
active
044774605
ABSTRACT:
This invention concerns the novel use of certain known thiazoles, particularly acylaminothiazoles and thiazolecarboxamides, as intraocular pressure lowering agents. When administered topically to the eye with increased intraocular pressure the compounds are effective in decreasing intraocular pressure, in preventing development of acute or chronic ocular hypertension including glaucoma, in inhibiting the further deterioration of the eye due to intraocular hypertension, or in relieving the symptoms of already existing ophthalmic disease.
REFERENCES:
patent: 3709992 (1973-01-01), Schmeling et al.
patent: 3850945 (1974-11-01), Edwards
patent: 3897441 (1975-07-01), Edwards
patent: 3982010 (1976-09-01), Edwards
patent: 4064258 (1977-12-01), Lewis et al.
patent: 4259341 (1981-03-01), Baldwin et al.
Glaucoma Update-Krieglstein (ed.)-pp. 19-26 (1979).
Roszkowski A. Peter
Waterbury L. David
Dolezalova Hana
Krubiner Alan M.
Moran Tom M.
Robinson Douglas W.
Syntex (U.S.A.) Inc.
LandOfFree
Topical treatment of ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical treatment of ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical treatment of ocular hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1945145